Oral candidiasis: relation to systemic diseases and medications

نویسندگان

  • Xiaozhu Chu University of Pittsburgh, School of Dental Medicine

DOI::

https://doi.org/10.5195/d3000.2017.74

کلمات کلیدی:

oral candidiasis, disease, medication, xerostomia

چکیده

Background: Oral candidiasis is by far the most common oral fungal infection in humans. It is caused by the fungal organism Candida albicans. When the host is debilitated by other diseases and conditions, C. albicans, which is usually a part of the normal oral flora, can turn pathogenic and invade the host tissue to cause the infection. The purpose of this paper is to investigate the role of systemic diseases and medications in the development of oral candidiasis.

Methods: A total of 12 cases with code indicating oral candidiasis were collected from the University of Pittsburgh School of Dental Medicine Dental Registry and DNA Repository. The systemic diseases and medications were descriptively analyzed.

Results: 50% of the subjects had more than two systemic diseases. The most prevalent diseases were mental illnesses (50%), cardiovascular diseases (41.7%), and respiratory system diseases (33.3%). 50% of subjects were on polypharmacy therapies and 75% of subjects were taking medications that may contribute to oral candidiasis. Among the medications, antidepressants and inhalational corticosteroids may have strong potentials to cause oral candidiasis.

Conclusion: Oral candidiasis is associated with having systemic diseases and intake of medication, especially with those medications can cause xerostomia. As the number of systemic diseases and medications increases, the risk of developing oral candidiasis may increase too.

مراجع

Neville B, Damm D, Allen C, Bouquot J. (2009) Oral and Maxillofacial Pathology. 3rd ed. St. Louis: Saunders, an imprint of Elsevier. 213-224 p.

Elucidating the role of hyposalivation and autoimmunity in oral candidiasis. Billings M, Dye BA, Iafolla T, Grisius M, Alevizos I. Oral Dis. 2017 Apr;23(3):387-394. doi: 10.1111/odi.12626. Epub 2017 Feb 8. PMID: 27998016

Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity. Okada S, Puel A, Casanova JL, Kobayashi M. Clin Transl Immunology. 2016 Dec 2;5(12):e114. doi: 10.1038/cti.2016.71. eCollection 2016 Dec. Review. PMID: 28090315

The impact of cigarette/tobacco smoking on oral candidosis: an overview. Soysa NS, Ellepola AN. Oral Dis. 2005 Sep;11(5):268-73. Review. PMID: 16120112

Saliva-microbe interactions and salivary gland dysfunction. Baker OJ, Edgerton M, Kramer JM, Ruhl S. Adv Dent Res. 2014 May;26(1):7-14. doi: 10.1177/0022034514526239. Review. PMID: 24736699

Epidemiology and etiology of denture stomatitis. Gendreau L, Loewy ZG. J Prosthodont. 2011 Jun;20(4):251-60. doi: 10.1111/j.1532-849X.2011.00698.x. Epub 2011 Apr 4. Review. PMID: 21463383

Candidal overgrowth in diabetic patients: potential predisposing factors. Belazi M, Velegraki A, Fleva A, Gidarakou I, Papanaum L, Baka D, Daniilidou N, Karamitsos D. Mycoses. 2005 May;48(3):192-6. PMID: 15842336

Fungal infections of the oral mucosa. Krishnan PA. Indian J Dent Res. 2012 Sep-Oct;23(5):650-9. doi: 10.4103/0970-9290.107384. Review. PMID: 23422613

Risks for oral health with the use of antidepressants. Peeters FP, deVries MW, Vissink A. Gen Hosp Psychiatry. 1998 May;20(3):150-4. Review. PMID: 9650032

Inhalational and topical steroids, and oral candidosis: a mini review. Ellepola AN, Samaranayake LP. Oral Dis. 2001 Jul;7(4):211-6. Review. PMID: 11575870

##submission.downloads##

چاپ شده

2017-06-19

شماره

Vol 5, No 1 (2017)

نوع مقاله

Mechanisms of Oral Disease

مجوز

Authors who publish with this journal agree to the following terms:

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site;
    with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
  4. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.
  5. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
  6. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
  7. The Author represents and warrants that:
    1. the Work is the Author’s original work;
    2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
    3. the Work is not pending review or under consideration by another publisher;
    4. the Work has not previously been published;
    5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
    6. the Work contains no libel, invasion of privacy, or other unlawful matter.
  8. The Author agrees to indemnify and hold Publisher harmless from Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Revised 7/16/2018. Revision Description: Removed outdated link.